meclizine and oxytetracycline, anhydrous

meclizine has been researched along with oxytetracycline, anhydrous in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
DUNLOP, IC; FARRAR, JF; GRAY, JB; HARLEY, JD1
FARRAR, JF; HARLEY, JD1
FRASER, FC1
BERGWALL, WL; CHRISTIE, RW1

Reviews

1 review(s) available for meclizine and oxytetracycline, anhydrous

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for meclizine and oxytetracycline, anhydrous

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
AROMATIC DRUGS AND CONGENITAL CATARACTS.
    Lancet (London, England), 1964, Feb-29, Volume: 1, Issue:7331

    Topics: Abnormalities, Drug-Induced; Acetaminophen; Acetazolamide; Anti-Bacterial Agents; Cardiovascular Agents; Cataract; Chloramphenicol; Communicable Diseases; Female; Histamine H1 Antagonists; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meclizine; Muscle Relaxants, Central; Nitrofurantoin; Oxytetracycline; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Progesterone; Sulfamethoxypyridazine; Sulfisoxazole; Sympathomimetics; Tetracycline; Toxicology

1964
MATERNAL DRUG THERAPY AND CONGENITAL CATARACTS.
    The Medical journal of Australia, 1964, Feb-08, Volume: 1

    Topics: Abnormalities, Drug-Induced; Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Antipyretics; Appetite Depressants; Cataract; Chloramphenicol; Female; Histamine H1 Antagonists; Humans; Infant, Newborn; Maternal-Fetal Exchange; Meclizine; Oxytetracycline; Pregnancy; Progesterone; Pyridoxine; Sulfamethoxypyridazine; Sulfanilamide; Sulfanilamides; Sulfisoxazole; Sulfonamides; Tetracycline; Toxicology

1964
EXPERIMENTAL TERATOGENESIS IN RELATION TO CONGENITAL MALFORMATIONS IN MAN.
    World-wide abstracts of general medicine, 1964, Volume: 7

    Topics: Abnormalities, Drug-Induced; Animals; Anti-Bacterial Agents; Caffeine; Cortisone; Insulin; Lagomorpha; Meclizine; Mice; Oxytetracycline; Protein Synthesis Inhibitors; Rabbits; Rats; Research; Sodium Salicylate; Teratogenesis; Tetracycline; Thalidomide; Thyroxine; Toxicology

1964
CONGENITAL LEUKEMIA.
    The Journal of the Indiana State Medical Association, 1964, Volume: 57

    Topics: Antifungal Agents; Communicable Diseases; Dextropropoxyphene; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Leukemia; Meclizine; Nitroglycerin; Ointments; Oxytetracycline; Penicillins; Phenylephrine; Poliovirus Vaccines; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Tetanus Toxoid; Toxicology; Vitamins

1964